JOSEPH KASS to United States Food and Drug Administration
This is a "connection" page, showing publications JOSEPH KASS has written about United States Food and Drug Administration.
Connection Strength
0.124
-
Cutaneous Adverse Effects of Neurologic Medications. CNS Drugs. 2016 Mar; 30(3):245-67.
Score: 0.124
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.